Skip to content

Failing Epidural Analgesia During Labor

Analysis of the Incidence and Risk Factors of Epidural Analgesia Failure During Labor: A Prospective Multicenter Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07473609
Acronym
FEA25
Enrollment
500
Registered
2026-03-16
Start date
2026-01-12
Completion date
2027-02-12
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Failed Epidural Analgesia, Post-partum Recovery

Keywords

Labor analgesia, intrapartum cesarean delivery, failed epidural analgesia, breakthrough pain, epidural catheter re-siting, ObsQoR-10

Brief summary

This prospective multicenter observational study is being conducted at the Gregorio Marañón University General Hospital and the La Paz University Hospital in Madrid, Spain. The recruitment period began on January 12, 2026, and will continue until February 12, 2027. Patients over 18 years of age requesting epidural analgesia for labor are included. Exclusion criteria are: age under 18; stillbirth; continuous spinal anesthesia; refusal to participate in the study. The primary objective of the study is to calculate the incidence of epidural analgesia failure during labor. Secondary objectives are: identification of potential risk factors for epidural analgesia failure; failure of epidural anesthesia for emergency cesarean birth; maternal postpartum recovery at 24 and 48 hours using the Spanish-validated version of ObsQoR-10 questionnaire.

Interventions

OTHERNo Intervention: Observational Cohort

No intervention: observational study

Sponsors

Nicolas Brogly
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Parturient who requests epidural analgesia for labor

Exclusion criteria

* Age under 18 years * Stillbirth * Continuous spinal anesthesia * Refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Failed epidural analgesia during laborAll duration of labour (from admission to labour ward until delivery) in patients with an initial adequate pain relief after epidural analgesia initiation.Persistence of pain 20 minutes after one top-up bolus of local anesthetic administered by the anesthesiologist, in a previously working epidural analgesia.

Secondary

MeasureTime frameDescription
Failed onset of epidural blockAn incomplete or inefficient block 30 minutes after initiation of epidural analgesia will be considered as a failed onset.Absence or insufficient epidural block in level and/or density in the first 30 minutes after the administration of the induction bolus.
Failed conversion of epidural analgesia to anesthesia for intrapartum cesarean birthIn subpopulation of patients with an intrapartum cesarean delivery, failed conversion will be considered for any requirement for intravenous supplementation or general anaesthesia during caesarean delivery.Requirement for a new regional block, intravenous supplementation or general anesthesia for an intrapartum cesarean birth in a patient with labor epidural analgesia.
Maternal recovery until 48h postpartumOn postpartum day 1 (24h after delivery) and day 2 (48h after delivery), during post-partum anaesthesia visit, the participants will answer the 10-Items Obstetric Quality of Recovery scoring tool (ObsQoR-10).Measurement of maternal recovery at 24 and 48 hours postpartum using the Spanish-validated version of 10-Items Obstetric Quality of Recovery scoring tool (ObsQoR-10). This 0-100 points score includes: * 4 items concerning postpartum side effects, rated from 0 to 10, with higher scores corresponding to lower intensity of side effects, * 6 items concerning postpartum recovery variables, rated from 0 to 10, with higher scores corresponding to better postpartum recovery.

Countries

Spain

Contacts

CONTACTNicolas Brogly, MD, PhD
nicolas.brogly@salud.madrid.org+34 663676820
CONTACTFrancisco Galván-Román, MD
franciscojesus.galvan@salud.madrid.org+34 691246504

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026